Trials
Search / Trial NCT06426446

Monitoring Patients With Severe Obesity Treated With Wegovy® Using Connected Device: Real-world Data

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · May 17, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Not yet recruiting

Keywords

Obesity Wegovy Semaglutide 2.4 Mg/Week

ClinConnect Summary

Obesity is a chronic disease associated with numerous co-morbidities. New treatments for obesity, notably GLP-1 (Glucagon-like peptide 1) analogs, have led to promising advances. Semaglutide 2.4 mg weekly subcutaneous injection, marketed under the brand name Wegovy®, was recently approved in France for weight loss in patients with severe obesity and at least one comorbidity. Several real-world studies have confirmed the effectiveness of semaglutide in reducing body weight and HbA1c. However, few studies have evaluated the kinetics and interindividual variability of changes in body weight an...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Man or woman aged over 18 years
  • • Patients who have reached the maximum dose of their treatment with Wegovy®
  • • Written consent
  • Exclusion Criteria:
  • • Patient on AME (state medical aid)
  • • Pregnant or breastfeeding woman
  • • Patient who does not speak French
  • • Adults under legal protection

Trial Officials

Sébastien Czernichow, MD, PhD

Principal Investigator

Assistance Publique - Hôpitaux de Paris

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0